Literature DB >> 9339206

[Advantage of using tumor markers in colorectal and breast cancers. Guidelines of the American Society of Clinical Oncology (ASCO)].

V Trillet-Lenoir1, G Freyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9339206

Source DB:  PubMed          Journal:  Bull Cancer        ISSN： 0007-4551            Impact factor:   1.276


× No keyword cloud information.
  3 in total

1.  Cytokeratins and carcinoembryonic antigen in diagnosis, staging and prognosis of colorectal adenocarcinoma.

Authors:  Luís C Fernandes; Su B Kim; Delcio Matos
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

2.  Soluble POSTN is a novel biomarker complementing CA153 and CEA for breast cancer diagnosis and metastasis prediction.

Authors:  Li Jia; Guanhua Li; Na Ma; Aimin Zhang; Yunli Zhou; Li Ren; Dong Dong
Journal:  BMC Cancer       Date:  2022-07-12       Impact factor: 4.638

Review 3.  Breast cancer circulating biomarkers: advantages, drawbacks, and new insights.

Authors:  Andrea Ravelli; James M Reuben; Francesco Lanza; Simone Anfossi; Maria Rosa Cappelletti; Laura Zanotti; Angela Gobbi; Chiara Senti; Paola Brambilla; Manuela Milani; Daniele Spada; Paolo Pedrazzoli; Massimo Martino; Alberto Bottini; Daniele Generali
Journal:  Tumour Biol       Date:  2015-08-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.